Injection Drugs/HIV/Hep Publications

2025

• Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Martin NK, Hyshka E, Larney S. (2025). Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022. Int J Drug Policy. 137:104711.
• Gadimova, F; Jackson, J. (2025). Experiences of Healthcare Professionals Working in Injectable Opioid Agonist Treatment Programs: A Qualitative Thematic Analysis. Journal of Addictions Nursing. 36(1):p 46-52.
• Jackson, J; Ainsley, E; Perry, S; Gadimova, F; Ens, T; Cameron, T; Francisco, R; Hon, A; Kim, Y; McGill, E; Patel, T; Sodhi, S; Yu, J; Ginn, C. (2025). How Do We Move the Needle on Needle Debris? A Qualitative Interview Study With Reflexive Thematic Analysis, From SANDS (Strategies for Addressing Needle Debris Study). The Canadian Journal of Addiction. 16(1):p 24-34.

2020

• Bahji A, Yanagawa B, Lamba W. (2020). Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review. Canadian Journal of Addiction. 11(2): 13- 23.

2019

• Brooks HL, O’Brien D, Salvalaggio G, Dong K, Hyshka E. (2019). Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs. Drug & Alcohol Review.
• Elbatarny M, Bahji A, Bisleri G, Hamilton A. (2019). Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies. General Hospital Psychiatry. 57: 44-49.
• Yakovenko, I., Hyshka, E., Tyrrell, L., & Wild, T. (2019). Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs. Journal of Substance Abuse Treatment. 101, 67-71.

2018

• Lafferty, L., Rance, J., Wild, T.C., & Treolar, C. (2018). A policy analysis exploring hepatitis C risk, prevention, testing and treatment, and reinfection within Australia’s prisons.  Harm Reduction Journal, 15(1), 39.

2017

• Kushwaha S, Lalani Y, Maina G, Ogunbajo A, Wilton L, Agyarko-Poku T, Adu-Sarkodie Y, Boakye F, Zhang N, Nelson LE. (2017). “But the moment they find out that you are MSM…”: a qualitative investigation of HIV prevention experiences among men who have sex with men (MSM) in Ghana’s health care system. BMC Public Health. 17(1):770.

2016

• Maina GM, Caine V, Mill J, Wimmer R. (2016). Exploring the meaning of living with HIV as a chronic illness in Kenya: A narrative inquiry. Commun Med. 13(2):215-226.
• Maina G, Mill J, Chaw-Kant J, Caine V. (2016). A systematic review of best practices in HIV care. J HIV AIDS Soc Serv. 15(1):114-126.
• Caine V, Mill J, O’Brien K, Solomon P, Worthington C, Dykeman M, Gahagan J, Maina G, De Padua A, Arneson C, Rogers T, Chaw-Kant J. (2016). Implementation Process of a Canadian Community-based Nurse Mentorship Intervention in HIV Care. J Assoc Nurses AIDS Care. 27(3):274-84.

2014

• Maina G, Sutankayo L, Chorney R, Caine V. (2014). Living with and teaching about HIV: engaging nursing students through body mapping. Nurse Educ Today. 34(4):643-7.
• Masching R, Dell CA, Egan JP, McHugh NG, Lee D, Prentice T, Storm L, Thomas C, McGee A, Dale-Harris H. (2014). The Complexities of Accessing Care and Treatment: Understanding Alcohol Use by Aboriginal Persons Living with HIV and AIDS. Canadi J Aborig Community Based HIV/AIDS Res. 6(1):70-94.
• Mill J, Caine V, Arneson C, Maina G, De Padua A, Dykeman M. (2014). Past experiences, current realities and future possibilities for HIV nursing education and care in Canada. J Nurs Educ Pract. 4(5):183-198.

2013

• Hyshka E, Bubela T, Wild TC. (2013). Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making. Addiction. 108(3), 468-76.
• Kerr T, Small W, Hyshka E, Maher L, Shannon K. (2013). ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction. 108(7), 1270-6.
• Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. (2013). Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy. 8:35.

2012

• Hyshka E, Strathdee S, Wood E, Kerr T. (2012). Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 23(4), 261-70.
• Martin LJ, Houston S, Yasui Y, Wild TC, Saunders LD. (2012). Poorer physical health-related quality of life among Aboriginals and injection drug users treated with highly active antiretroviral therapy. Can J Public Health. 104(1), e33-8.

2011

• K. Lang, A. El-Aneed, S. Berenbaum, C. Dell, J. Wright, Z. Teed McKay. (2011). Qualitative Assessment of Crisis Services among Persons Using Injection Drugs in the City of Saskatoon. Journal of Substance Use. 18:1, pp. 3-11.

2010

• Martin LJ, Houston S, Yasui Y, Wild TC, Saunders LD. (2010). Rates of initial virological suppression and subsequent virological failure after initiating highly active antiretroviral therapy: the impact of aboriginal ethnicity and injection drug use. Curr HIV Res. 8(8), 649-58.

2007

• Wozniak L, Prakash M, Taylor M, Wild TC. (2007). Everybody’s got it, but…: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. Int J Drug Policy. 18(5), 388-96.